Laboratory

ART-TG – Technology Research Accelerator in Genomic Therapy

Genopole Campus 1 – CRCT
30 rue Henri Desbruères
91100 CORBEIL-ESSONNES – FRANCE
Téléphone : +33(0)1 45 59 52 40 / 41 – Email : art-tg@inserm.fr
Directrice : GALY Anne

Site Web >

#Genomics / Postgenomics #Biotherapies #Human Genomics

Gene therapy
Lentiviral vector
Biotechnology
CRISPR
Immunology
Genome
Hematology

Tutelle :

Domaine d'activité

Therapeutic areas of interest are immunotherapy (cancer or infectious diseases), gene therapy of genetic diseases of the blood or immune system, two fields with high innovation potential and need for genomic therapy developments.

The Technologyl Research Accelerator in Genomic Therapy (ART-TG) is an innovation center that was established to promote excellence in gene therapy research.

ART-TG is a pre-GMP stage R&D laboratory aiming to bridge a gap between research and clinical or industrial applications. It has pharmaceutical expertise for product development and product manufacturing, specifically for genomic therapy approaches.

ART-TG provides an R&D platform allowing on the one hand to develop products for clinical applications, and on the other hand to set up the manufacturing processes and control of gene therapy products. Focusing more specifically on immunotherapy and hematology, ART-TG provides technological, preclinical and pharmaceutical skills. ART-TG works on improving the bioproduction processes of lentiviral vectors. ART-TG is also developing innovative approaches for the immunotherapy of infectious diseases or for the treatment of genetic diseases such as sickle cell anemia. The ART-TG is located south of Paris at the Genopole biocluster in Evry which supports its activities.

COLLABORATION / CHAIRE

ART-TG collaborates with the following Inserm units:
– Integrare-UMR-S951 at Genethon in Evry,
– Inserm U955-eq16 of the Vaccine Research Institute in Créteil,
– Inserm UMR-S1163 of the Institute Imagine in Paris.

At the international level ART-TG collaborates with:
– the Fred Hutchinson Institute in Seattle, WA USA,
– the CHUV Hospital in Lausanne, CH

Genopole’s Laboratories

#Genomics / Postgenomics

In same field

LBEPS

LBEPS is a laboratory dedicated to the physiology and biology of exercise implementing a translation strategy from the physiology of humans in motion to the study of cellular, molecular, genetic and epigenetic responses to exercise and recovery

Discover

I-Stem

The institute evaluates the therapeutic potential of all types of stem cells in the setting of monogenic diseases.

Discover

Genethon

Gene therapy for rare genetic diseases. Research, preclinical and clinical development of gene therapies for neuromuscular and other rare genetic diseases.

Discover

LGRK

Research at LGRK focuses on the homeostasis, regenerative potential and radiosensitivity of human epidermal stem cells.

Discover

INTEGRARE

The Integrare research unit aims to develop effective and safe gene therapies for rare genetic diseases such as neuromuscular disorders, metabolic diseases or blood/immune disorders

Discover

Genoscope – CNS

Genomics and postgenomics of biodiversity – Metagenomics of microorganisms from the environment.

Discover

Genomics Metabolics

The Metabolic Genomics UMR is the fundamental research structure of Genoscope – National Sequencing Center – Study of the chemistry and the diversity of organisms. Genomics of eukaryotes, prokaryotes and metagenomes.

Discover

GenHotel

Genomics – Genetic Statistics Research on genetic susceptibility to complex diseases through genomic analyses with a focus on rheumatoid arthritis.

Discover

EPGV

Plant genomics. Detection, analysis and management of plant species polymorphism.

Discover

CNRGH

The CNRGH is a national-level center whose mission is to provide high throughput genotyping and sequencing services with the objective of optimizing genetic and genomic research for human diseases.

Discover

View all >

With the support from